Clicky

Entera Bio Ltd.(ENTX)

Description: Entera Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The Company is initially applying its technology to develop an oral formulation of parathyroid hormone (PTH) for hypoparathyroidism (EB612) and osteoporosis (EB613).


Keywords: Biopharmaceutical Osteoporosis Endocrine System Hormones Thyroid Molecule Therapeutics Glands Parathyroid Hormone Hypoparathyroidism

Home Page: www.enterabio.com

ENTX Technical Analysis

Kiryat Hadassah Minrav Building
Jerusalem, 9112002
Israel
Phone: 972 2 532 7151


Officers

Name Title
Ms. Miranda J. Toledano M.B.A. CEO & Director
Dr. Hillel Galitzer M.B.A., Ph.D. Chief Operating Officer
Ms. Dana Yaacov-Garbeli CPA CFO & Principal Financial Officer
Dr. Arthur C. Santora II, M.D., Ph.D. Chief Medical Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.2615
Price-to-Sales TTM: 63.3717
IPO Date: 2018-06-28
Fiscal Year End: December
Full Time Employees: 19
Back to stocks